Simple and sensitive LC–MS/MS method for simultaneous determination of crizotinib and its major oxidative metabolite in human plasma: Application to a clinical pharmacokinetic study-Reference-Cited by-同舟云学术

Simple and sensitive LC–MS/MS method for simultaneous determination of crizotinib and its major oxidative metabolite in human plasma: Application to a clinical pharmacokinetic study

Published:2018-06 Issue: Volume:155 Page:210-215
ISSN:0731-7085
Container-title:Journal of Pharmaceutical and Biomedical Analysis
language:en
Short-container-title:Journal of Pharmaceutical and Biomedical Analysis

Author:

Qi Xiaoyan,Zhao Lin,Zhao Qiuping,Xu Qiaoxia

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry

Reference11 articles.

1. Evaluation of crizotinib absolute bioavailability, the bioequivalence of three oral formulations, and the effect of food on crizotinib pharmacokinetics in healthy subjects;Xu;J. Clin. Pharmacol.,2015

2. ALK translocation and crizotinib in non-small cell lung cancer: an evolving paradigm in oncology drug development;Scagliotti;Eur. J. Cancer,2013

3. Structure based drug design of crizotinib (PF-02341066) a potent and selective dual inhibitor of mesenchymal-epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase, (ALK);Cui;J. Med. Chem.,2011

4. Gender specific drug metabolism of PF-02341066 in rats-role of sulfoconjugation;Zhong;Curr. Drug Metab.,2010

5. Pharmacokinetics of crizotinib in NSCLC patients;Hamilton;Expert Opin. Drug Metab. Toxicol.,2015

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of CYP3A4 genetic polymorphism on crizotinib metabolism and drug-drug interactions;Toxicology and Applied Pharmacology;2024-08

2. Simultaneous determination of unecritinib (TQ-B3101) and its active metabolite crizotinib in rat plasma by LC-MS/MS：An application to pharmacokinetic studies;Journal of Pharmaceutical and Biomedical Analysis;2024-08

3. Current Bioanalysis of Molecularly Targeted Drugs Using Liquid Chromatography–Tandem Mass Spectrometry;CHROMATOGRAPHY;2023-06-20

4. Crizotinib: A comprehensive profile;Profiles of Drug Substances, Excipients and Related Methodology;2023

5. Development and validation of a novel LC-MS/MS method for simultaneous quantitative determination of tyrosine kinase inhibitors in human plasma;Journal of Chromatography B;2022-10